WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential … WebApr 10, 2024 · CYTK. KK3A. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 …
VC Kristina Simmons, a veteran of a16z and Khosla Ventures, …
WebOct 17, 2024 · CYTK has a market cap of $4.33bn and a cash balance of $596mn. This does not include the $383mn in net proceeds from a $450mn convertible debt offering the company made in June. I am a little... WebMar 31, 2024 · Cytokinetics Incorporated (CYTK) full year performance was -9.34%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cytokinetics Incorporated shares are logging -37.58% during the 52-week period from high price, and … ira mandatory withdrawal 2021 calculator
FedEx (NYSE:FDX) Price Target Raised to $275.00
WebJan 6, 2024 · This is the sentence provided by the FDA's briefing document regarding the new drug application for Cytokinetics, Inc.'s ( NASDAQ: CYTK) omecamtiv mecarbil ("OM") on December 13th, 2024. For longs ... WebFeb 28, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... WebCYTK: Cytokinetics EPS. Get the latest EPS stock quote information from Zacks Investment Research. orchids online nursery